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Abstract
Diabetes is on a global rise and there is a definite gap in providing care for the diabetic
population. Two of the largest contributors to this gap in care are the lack of collaboration
between health care professionals and the lack of education for health care providers on
the evolution of diabetes treatment plans. This educational module is aimed to improve
the management of care, and quality of life for patients living with diabetes, by providing
education to health care providers on an alternative way to administer insulin therapy.
The describing, analyzing, theorizing, and act, (DATA) model, and the theory of
organizational change, were utilized in the development of this educational module. The
key project question addressed the following: When health care providers are educated on
the guidelines and effectiveness of the inhaled insulin, Afrezza, this educational module
would improve professional knowledge when managing the care of patients living with
diabetes. Quantitative and qualitative information were gathered by review of peerreviewed articles and published, evidence-based practice guidelines. The pre-and posttest
for the educational program outcomes and quality improvement measures were
influenced by the Kirkpatrick evaluation model. This educational module was used to
promote knowledge in the health care profession by providing education to twenty health
care providers and stakeholders on the guidelines for the use, benefits, and effectiveness
of using the inhaled insulin, Afrezza. The outcomes of this project resulted in an overall
gain of 137.3% of knowledge on the use of inhaled insulin, Afrezza. The Food and Drug
Administration has approved Afrezza, and with its use can promote positive social
change, by reducing the number of daily injections, improve the quality of life for
patients living with Diabetes, and reduce environmental biohazard materials globally.
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This is dedicated to the lifelong commitment and sacrifice for all of the
population that is living with diabetes and to all of the health care providers that are
devoting their time and effort in helping improve the quality of life for others.
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Section 1: Nature of the Project
Introduction
Diabetes is a group of chronic disease that is defined by hyperglycemia because
of abnormal metabolism of carbohydrates and glucose due to the body’s inability to
respond to or produce the hormone insulin.(American Diabetes Association,2020).
Diabetes does not discriminate against age, race, or gender. The number of patients living
with diabetes is increasing and there are two significant contributing factors that are
related to poor health care management of this patient population: the lack of
collaboration between health care professionals and the lack of education for health care
providers on the evolution of diabetes treatment plans.( Centers for Disease Control and
Prevention,2021).
One of the most significantly used drugs within the treatment regimens of Type 1
and Type 2 diabetes is insulin. Many people living with diabetes receives five or more
injections of insulin daily to keep their glucose levels controlled.( Edelman & Pettus,
2020). Injectable insulin has been on the market since its introduction in 1921 by Banting
and Best from the University of Toronto.( Vecchio et al., 2018). Although another option
to administering Insulin has been introduced almost a century ago by German
researchers, it has been greatly down played and overlooked in the health care industry.
This other method of insulin administration, by the route of inhalation and called
Afrezza, is now approved by the Food and Drug Administration (FDA) and would reduce
the number of daily injections for patients living with diabetes.
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The ultimate goal in the development of this educational module project was to
improve, support, and educate the global population on the benefits of using the inhaled
insulin, Afrezza, by means of educating health care providers first. Identifying gaps
within health care providers knowledge on the utilization of the inhaled insulin, Afrezza,
and developing an educational module for the improvement of their knowledge base,
could promote positive change when managing diabetes. This educational module could
promote collaboration between health care providers, improve the quality of life for
patients living with diabetes, and improve clinical outcomes. I designed this educational
module to inform health care providers of the possibility to take a part in two major
global focus points when managing diabetes: (a) the use of the inhaled insulin, Afrezza,
could decrease global biohazardous waste, such as insulin syringes. and (b) the use of the
inhaled insulin, Afrezza, could decrease the global expenditure on diabetes management
and the multiple comorbidities that couple with having diabetes.

Problem Statement
Diabetes is on a global rise, and there is a definite gap in providing care for the
population of people living with diabetes.( Cleveland Clinic, 2021). One of the largest
gaps in providing care for patients living with diabetes is ensuring that health care
providers stay apprised on the ever-evolving diabetic treatment plans and medication
regiments. Another identified gap is individualizing diabetes plans of care according to a
patient’s needs to assure adherence to prescribed treatment regimens. Living with
diabetes, and trying to accomplish controlled glucose levels is a life-long commitment
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that takes dedication and work, not only from the patients but the health care providers as
well. At times a person living with diabetes can experience diabetic fatigue, loose hope,
and fall back into the patterns of unhealthy behavioral lifestyles due to lack of clinical
support, or not making the commitment to give themselves four or more insulin injections
along with four or more blood glucose checks daily.
The American Diabetes Association (ADA, 2018) estimated that the total costs of
diagnosed patients living with diabetes has risen to $327 billion in 2017 from $245
billion in 2012; this was a 26% increase over a 5-year period. According to the ADA the
total expenditure of $327 billion, when broken down into various categories would be as
follows: $237 billion is in direct medical costs, and $90 billion was in reduced
productivity, meaning 30% is inpatient hospital care, 30% prescription medications from
complications of diabetes, 15% antidiabetic agents and supplies and 13% for health care
provider visits. For their diabetes management alone, a projected yearly medical expense
for each individual patient living with diabetes is at least $16,752.
(GlobeNewswire,2020).
Identifying gaps within health care providers knowledge base and providing
education on the use of the inhaled insulin, Afrezza, can promote an alternative method to
managing glucose levels. The utilization of this alternative method for the management
for diabetes could improve the quality of life, promote medication adherence, and
ameliorate health outcomes for patients living with diabetes. The adherence to
individualized care plans for patients living with diabetes could help with the reduction of
rehospitalizations due to the multiple comorbidities that are attributed to diabetes. The
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reduction of rehospitalizations due to improved medical adherence would, in turn, help
with the reduction of the overall global health care expenditure due to diabetes
management.

Purpose Statement
There are two major contributors to the gap in providing health care for diabetes
management: the lack of collaboration between health care professionals and the lack of
education for health care providers on the most current practice guidelines for
individualized treatment plans for patients living with diabetes. It is almost impossible for
a health care provider to stay apprised on the ever-evolving diabetic treatment plans and
the preferred medication regiments that are on the pharmaceutical market. There are
many different medication regiments for the treatment of diabetes, creating an
overwhelming information for health care providers to make decisions with when treating
patients living with diabetes.
The guiding practice-focused questions for this project were:
1. If health care providers are educated on the guidelines for the use,
administration, and effectiveness of using the inhaled insulin, Afrezza, will
they be more likely to utilize this medication regimen?
2.

Will the development of this educational module improve collaborative
measures within the health care professional’s practice for both growth and
improvement when managing the care of patients living with diabetes?

5
Over centuries, there have been many different treatments and practice guidelines
that have emerged for diabetes management. However, one of the primary health goals
of Centers for Disease Control and Prevention, (CDC) and Healthy people 2030 has not
changed in the last 10 years. The goal of reducing the burden of diabetes and improving
the quality of life for the population of people living with diabetes still plays a vital part
in health care (Office of Disease Prevention and Health Promotion, 2021).
There have been many studies and documented testimonials that show that the
combination of the use of the inhaled insulin, Afrezza, and continuous glucose monitors
(CGMs) is proven to be beneficial. (Afrezza.2021; Edelman & Pettus, 2020; MannKind
Corporation,2020; Pettus, 2021). The advantages reported were reducing three or more
daily insulin injections and decreasing patients sticking their fingers at least four or more
times daily in order to adjust insulin dosages in correlation to their glucose levels. This is
a total reduction of 210 or more sticks and injections monthly, and 2,520 or more sticks
and injections yearly. (MannKind Corporation, 2020). An Inhaled insulin treatment
regimen for Type 1 and Type 2 diabetes mellitus is literally changing patients’ lives and
allowing them to control their glucose levels in a healthier, safer and more manageable
fashion. Another benefit of the use of inhaled insulin is the overall expenditure in
diabetes management costs will be reduced along with the reduction of biohazard
materials, such as used hypodermic needles and syringes.
Nature of the Doctoral Project
To provide quality, effective patient care, it is necessary for health care providers
to recognize when they are deficient or lacking in education in specific areas of their
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training and seek continuing education for these deficiencies. I used two different guides
to create the outline for this educational project: Bloom’s Taxonomy, The American
Association of Colleges of Nursing’s (AANC) The Essentials of Doctoral Education for
Advanced Nursing Practice.
During the formation of this educational module, I used a well-developed
framework for effective development and evaluation for advancement in knowledge to
focus on key components. Both quantitative and qualitative information centered on
evidence-based research were retrieved and reviewed. The research content for this
project contains current practice guidelines and statistical facts with the intent to promote
quality patient care as well as improving patients’ quality of life and clinical practices.
I combined a model and a theory as the conceptual framework for this project.
The DATA model was used to help develop this educational module for improvement of
health care management of diabetes and endocrinology patients. The theory of
organizational change was also used to develop this particular program for improving
diabetes management.
During the evaluation I intended to analyze outcomes; however, evaluation was
an ongoing activity that actually started at the beginning of the formulation of the
research plan and that continued even after the interventions were completed. With this
program, a pre and posttest was given to the participating health care providers to
evaluate their knowledge level on five specific areas of focus with the management of
diabetes: diabetes treatment regimens; diabetes drug class updates; the guidelines for
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treating with the inhaled insulin, Afrezza; and the health care provider’s collaborative
practice habits when managing diabetes.
The use of the pre- and posttest in this project was influenced by the Kirkpatrick
evaluation model. Several researchers have noted that Kirkpatrick’s approach has been
popular as a model for evaluating learner outcomes in various training programs.(Kurt,
2018). This model has contributed to educational evaluation with focus on program
outcomes through the evaluation of how well the content was absorbed. There are four
different stages of evaluation: formative, process, impact and outcome.( Kurt, 2018).
Each stage begins at different times in a research study process.
The aim for this education module was to help close the gap within health care
practice when managing the care of patients living with diabetes by improving healthcare
providers’ knowledge base on the use of the inhaled insulin, Afrezza. Afrezza use has
shown to be of benefit to some patients living with diabetes and many health care
providers that manage the care patients with diabetes (Edelman & Pettus 2020). This
education module can help improve collaborative practice, health outcomes, eliminate
rehospitalizations due to the multiple comorbidities that are attributed to diabetes, and
reduce overall global health care expenditure due to diabetes management. It is
necessary for health care providers to collaborate with other health care professionals and
to stay apprised to the ever evolving diabetes treatment plans and medication regiments.
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Significance
When planning an educational program, it is important to outline program goals
and objectives to address the targeted population and stakeholders. This program
enhanced health care providers’ knowledge by developing an educational module on the
use of the inhaled insulin, Afrezza. This educational module could improve and promote
individualized patient care plans. I developed this program to promote collaboration with
subsequent health care providers or specialist to improve continuity and quality of care
for patients that are living with diabetes.
When trying to form an educational program for health care providers that
manage care for diabetes, it is important to focus on who the stakeholders are. The
stakeholders that were most prevalent in my ideation of this program were, first and
foremost, the patients, to improve their overall health and lower medical costs. The
second stakeholder was the various governmental agencies and insurance companies with
incentives to cut medical spending for the management of diabetes due to decreased
medications, supplies, and hospitalizations from other comorbidities in direct correlation
with diabetes. The third stakeholder was the health care providers with an incentive of
having improved knowledge base, patient outcomes and success with providing quality
care. One of the most important stakeholders would be the global population of people
living with diabetes, with the incentive to improve quality of life, decrease the number of
injections taken daily, and have improved health outcomes.
At an organizational level, proper evidence has to be provided showing that an
educational program is needed, which can be accomplished by collecting data,
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identifying and educating stakeholders with this supported data. Recent estimates
showed the global prevalence of diabetes to be 382 million people in 2013, and this
number is expected to increase to 592 million by 2035. (Gandhi & Wareham, 2016)
There are endless amounts of data that has already been collected by multiple
organizations, including the ADA, American Nurses Association, Association of
Diabetes Care and Education Specialist, etc. that support the fact that Type 2 diabetes is
preventable and yet it continues to occur due to unhealthy lifestyles. (Office of Disease
Prevention and Health Promotion, 2021). Many changes in health care and the
development of integrated delivery systems have expanded healthcare providers’ efforts
to acquire new information about more efficient approaches that enhance disciplinespecific and interdisciplinary contributions to improved patient outcomes. Both Type 1
and Type 2 diabetes can lead to multiple systemic complications. Involving
microvascular problems, such as retinopathy, neuropathy, and nephropathy along with
macrovascular problems such as cardiovascular disease, stroke, peripheral vascular
disease, and kidney disease (ADA, 2018) .
I developed this educational module with the following goals related to providing
positive social change:
•

Helping health care providers stay apprised of and educated on the evolution of
an alternative method of administering insulin.
•

Improving the quality of life for the population living with diabetes.

•

Reducing health care costs.

•

Reducing biohazardous materials to promote eco-friendly measures.
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Summary
The educational program developed for this project provides information on the
guidelines for use, administration, references, benefits, and effectiveness of using the
inhaled insulin, Afrezza. This program supports collaborative measures between health
care professionals when managing diabetes.
This educational program was one method of taking steps to help improve care
for the population of people living with diabetes as well as health care providers’
knowledge and practice utilizing evidence-based information. According to Kettner et,
al., (2017), “ In effectiveness-based program planning, one should be able to make
explicit two things about a program: 1. The results that are to be achieved and 2. The
manner in which these results will be achieved” (p. 11).
Creating a pre- and posttest that identified gaps in healthcare providers’
knowledge base on the management of diabetes could make a positive impact in
identifying areas of need in their educational process. It is necessary for health care
providers to recognize when they are deficient or lacking in education in specific areas of
their training and seek continuing education for these deficiencies to avoid providing
poor patient care and medical errors. Health care providers want to provide quality,
efficient care and help their patient population with their health issues. Health care
providers have an obligation to the patients to be proactive and help form strategic plans
and policies that help improve patient populations’ overall health outcomes. The term
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beneficence is defined as the obligation of a health care provider to help people that are in
need (Bodenheimer & Grumbach, 2016).
Injectable insulin has been highly utilized since the 1920’s for glycemic control
for patients living with diabetes; however, there is now an FDA- approved alternative
method for the administration of insulin that can promote an improved quality of life for
this patient population. The development of this educational program could be beneficial
for healthcare providers, patients, governmental funding agencies, insurance companies,
and the global population.
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Section 2: Background and Context
Diabetes is on a global rise and there is a definite gap in providing care for the
diabetic population. One of the largest gaps in providing care for patients living with
diabetes is ensuring that health care providers stay apprised on the ever evolving diabetic
treatment plans and medication regiments. Another identified gap is individualizing
diabetes plans of care according to a patient’s needs to assure adherence to prescribed
treatment regimens.
The guiding practice-focused question for this project were:
1. If health care providers are educated on the guidelines for the use,
administration, and effectiveness of the inhaled insulin, Afrezza, will they be
more likely to utilize this medication regimen for improvement in the quality
of life for patients living with diabetes?
2.

Will the development of this educational module improve collaborative
measures within the health care professional’s practice for the growth and
improve the management of care for patients living with diabetes?

The aim for this module was to help close the gap within healthcare practice when
managing the care of patients living with diabetes. Identifying gaps within healthcare
providers’ knowledge base and providing them with education on the use of the inhaled
insulin, Afrezza, could promote an alternative method to managing glucose levels. This
alternative method of insulin delivery, by route of inhalation, could improve the quality
of life, medication adherence, and health outcomes for patients living with diabetes.
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Improved adherence to individualized care plans for patients living with diabetes could
help in eliminating rehospitalizations due to the multiple comorbidities that are attributed
to diabetes and reducing the overall global health care expenditure due to diabetes
management. The Ultimate goal in the development of this educational program was to
improve, support and educate the global population on the benefits of using the inhaled
insulin, Afrezza, by means of educating healthcare providers first.
In this section, I discuss the following major areas of focus for this project:
1. The concepts, models and theories that are related to the development of
this project.
2. How this project will be relevant to nursing practice.
3. The local background and context for this project.
4. What my role as the Doctor of Nursing Practice (DNP) student was
throughout the development of this project.
5. A summarization of section 2 of this project.

Concepts, Models, and Theories
One of the key strategies for program planning is identifying a problem and its
etiology. (Kettner, et, al., 2017). Another key factor to focus on when analyzing for
program planning is determining the characteristics of a population. A program design is
identifying and conspiring the elements that make up the delivery of service. It is
important that the program planner is very specific within explaining the needs and how
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the program will service those problems by defining the expected results. (Kettner et, al.,
2017).
Designing a program for improvement within health care involves problem
solving, so it is important to choose a model that is based around the theory that will help
establish necessary steps to achieve desired outcomes. The model that seems most
appropriate for the improvement of health care management of diabetic and
endocrinology patients was the DATA model. The theory of organizational change
aligned closest with this particular program for improving diabetic management.
The DATA model focuses on reflective practice, which is one of the six essential
competencies. (Smith, et al., 2016). The letters in the DATA model refer to: D is for
describing what is has been happening within practice; A is for analyzing, and evaluating
what is currently happening in practice and answering the question of why is it
happening; T is for focusing on theorizing the practice, which follows sequence after the
analyzing step; and the second A is for act, which is for laying out and action plan to
change practice through theory. In 1933 educational philosopher, John Dewey,
influenced the formation of the DATA model by defining the meaning of reflection,
which later led to the work of Donald Schon in 1983 in the book, The reflective
practitioner: How Professionals Think in Action, and J.M. Peters in 1991 in the book
Strategies for Reflective Practice.
The theory of organization change focuses on the concepts of identifying and
defining the problem, action initiation, implementation of change, and promoting
institutional change (Smith et al., 2016). The theory of organization change provides
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many different organizations with ways to expand and allow innovation through new
technologies and program design as well as promote obtaining new goals. This theory
and model both recognize that organizations evolve through a series of stages, and
moving from one stage to the next requires different sets of plans and aligned activities.
The evaluation of a program is essential in determining the areas of success and
how improvement measures are needed in order to improve outcomes. It is vital to
evaluate the impact of the program. Kettner et al. (2017) stated that “ An impact program
evaluation seeks to establish a cause-and effect relationship between a program and its
outcome results.” ( p 205). Kettner et al. emphasized that the primary purpose of program
evaluation is to provide feedback on results, accomplishments, or impacts; inform the
planners, policymakers and stakeholders about program effectiveness; and determine if
the correct social interventions, and hypotheses are being conducted.

The evaluation model most appropriate for this project was the Kirkpatrick
evaluation model. Dr. Kirkpatrick was a Professor at the University of Wisconsin and an
honorary chairman of Kirkpatrick Partners until passing away in 2014. Dr. Kirkpatrick
created the Kirkpatrick model in 1950 to evaluate a human relations training program for
supervisors, it has been the most widely recognized evaluation model globally for
training programs(Kurt,2018). The model has a four-level concept of program/training
evaluation: reaction, learning, behavior, and results.
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I utilized the Gantt chart to help communicate the detail involved in achieving the
project goals of this educational module. It allowed a demonstration of a constructed time
line of project progression throughout the entire project. The Gantt chart was useful for
the organization and tracking of this program goals in a timely manner and was a
valuable piece within the organizational arrangement of this project. (see White et al.,
2021).

Relevance to Nursing Practice
The global diabetes prevalence in 2019 was estimated to be 9.3% (463 million
people), and it is expected to accelerate to 10.2% (578 million) by 2030 and continue to
climb to 10.9% (700 million by 2045. (Saeedi et al., 2019). Both Type 1 and Type 2
Diabetes can lead to multiple systemic complications involving both microvascular and
macrovascular problems (ADA, 2018). Microvascular complications affect things, such
as retinopathy, neuropathy, and nephropathy, while macrovascular problems can occur,
such as cardiovascular disease, stroke, peripheral vascular disease, and kidney disease. It
is important to understand the reciprocal relationship between diabetes and vascular
disease due to the multiple comorbidities that concomitantly occur (ADA, 2018).
Type 2 Diabetes has been identified with being in direct correlation with poor
eating habits, obesity, unhealthy lifestyles, medication regimen adherence, and lack of
proper education (ADA, 2020). Many lifestyles can be a contributing factors to the
development of Type 2 diabetes; however, two of the most profound joint associations is
obesity, and medical non-compliance ( ADA, 2020). Obesity can be a genetic factor or
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can be developed due to unfavorable lifestyles. There is a close relationship between type
2 diabetes (T2D) and obesity due to the significance of obesity in the development of
metabolic disorders. There is a direct relationship of free fatty acids in the blood and
visceral fat with insulin resistance. (Sheikhpour et al., 2020). Even though T2D was once
called “Adult onset Diabetes”, this classification has pretty much been eradicated from
use in the health professional terminology due to the rapid increase in prevalence of T2D
in children and adolescents due to childhood obesity.
Two identified health care gaps when providing care for the population of patients
living with diabetes were at the center of this project. One of the identified issues was
ensuring that health care providers are educated on the most up-to-date guidelines, and
treatment regimens available for treating diabetes. The second issue was the lack of
collaboration within health care providers when managing care for diabetes. Being a
health care provider that is caring for patients living with diabetes can be challenging at
times due to patients getting diabetic fatigue and lack of medication adherence. Nonadherence is often attributed to insulin administration and blood glucose checks
(Edelman & Pettus 2020). The endless amount of insulin injections, along with the
multiple finger sticks is a detouring factor with patient compliance.
Injectable insulin has been widely utilized for the treatment of both Type 1 and
Type 2 diabetes mellitus since 1921 (Vecchio et al., 2018). Since 2014 there has been a
FDA- approved alternative route for insulin administration by route of inhalation;
however, it is not used in abundance due to the lack of knowledge by many healthcare
providers (Edelman & Pettus 2020).
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The idea of inhaled insulin has been a concept for almost a century without apt
recognition. One research article, by Gillis (2006) reported that German researchers had
introduced the idea of inhalable insulin in 1924. There have been many years of trials on
finding ways to properly administer inhaled insulin, and success was accomplished when
scientists realized that with the utilization of technology, insulin could be turned into a
powder that had particles correctly sized for inhalation. Over many years of investment
and research with several failed attempts from multiple drug companies, in June of 2014,
the FDA approved the use of Afrezza inhaled insulin for both Type 1 and Type 2 adult
diabetics. According to results presented at the 2018 meeting of the ADA, Afrezza
increases the time that blood glucose levels remain in optimal range (70-180 mg/dl),
reducing both spikes in blood glucose and time in hypoglycemia in adults with Type 1
diabetes compared to other rapid acting insulins (Snell-Bergeon et al., 2018). Despite the
fact that an FDA- approved, rapid acting, inhaled insulin has been commercially available
for diabetic patients since 2014, a large population of healthcare providers are unaware of
its existence, indications for use, management guidelines, dosing, and prescribing
methods. With the combined use of CGM’s and Inhaled insulin as an alternative to
multiple insulin injections and numerous finger sticks before insulin administration,
patients have increased compliance to medication regimens, decreased A1C levels and
daily average glucose levels (Edelman & Pettus,2021).
One of the goal for the development of this evidence-based practice educational
program on the use of the inhaled insulin, Afrezza, was to help keep health care providers
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apprised and educated on the evolution of new and improved ways to treat patients living
with diabetes. Some of the other goals that are focused on are:
•

For health care providers to recognize deficiencies in their knowledge base for
diabetes management.

•

Improve the overall quality of care for patients living with diabetes.

•

Improve clinical practice for health care providers when caring for patients living
with diabetes.

Local Background and Context
For the success of a human service program, it is important to focus on the actual
lives that the program will be affecting and helping. Understanding the limitations and
barriers of a specific population and adjusting to their culture is a large step towards
health care improvement and the success of saving lives (White et al., 2020).
The two groups that will provide the most accurate feedback from the program
implementation for the improvement of diabetes management by enhancing health care
providers’ knowledge on the use of inhaled insulin would be the population living with
diabetes and Healthcare providers. More often than not, patients want to improve their
health and want to cease disease processes; however, some patients do not have access to
proper health care, are not educated properly, or cannot afford proper medications for the
most effective treatment for their diabetes. Health care providers could benefit from this
educational module by having improved patient outcomes and quality of life for their
patients as well as success with providing quality care. Health care teams are vital in
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helping people that are living with diabetes manage their disease and have a quality life
(CDC, 2021). It is imperative that health care providers stay apprised on the evolution of
modern technologies and medication regiments for patients, including diabetic
management. The interrelationship was applied in refining my evidence-based practice
project by utilizing my knowledge base from previous experiences and the understanding
of theory based interventions.

Role of the DNP Student
The DNP student has many roles and expectations beyond just advancing in levels
of education in the hierarchy of the profession. One of these roles has to do with
scholarship, “ Defining Scholarship: Nursing scholarship is the generation, synthesis,
translation, application, and dissemination of knowledge that aims to improve health and
transform health care” (AACN, 2018, p.2). This definition is essential in the application
for any level of education within the nursing profession.
The Institute of Medicine (2010), lead a study with an interdisciplinary committee outlining
four recommendations for effective practice within the nursing profession:
1. Should practice to the full extent of their education and training.
2. Should achieve higher levels of education and training through an improved
education system that promotes seamless academic progression
3. Be full partners, with physicians and other healthcare professionals, in
redesigning health care in the United States.
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4. Engage in effective workforce planning and playmaking that requires better
data collection and an improved information infrastructure (p. 1).
As the recommendations were transitioned to action and policy, the need to expand
access through doctoral education for nurses was imperative. (The National Academies of
Sciences Engineering Medicine. 2021).
It is necessary for health care providers to recognize when they are deficient or
lacking in education in specific areas of their training and seek continuing education for
these deficiencies, in order to provide quality, effective patient care. I have utilized three
different guides in order to create the outline for my doctoral project. The three guides are
Bloom’s Taxonomy, The American Association of Colleges of Nursing’s, The Essentials
of Doctoral Education for Advanced Nursing Practice.
Bloom’s Taxonomy was created in 1956 by Benjamin Bloom and collaborators,
Englehart, Furst, Hill and Krathwohl in order to provide framework for educational goals.
Over the decades the original Taxonomy of 1956 has been revised by many different
authors including psychologist, curriculum theorists and researchers.
The definition of advanced nursing practice according to the AACN, (2020).
Any form of nursing intervention that influences health care outcomes for
individuals or Populations, include the direct care of individual patients,
management of care for individuals and populations, administration of nursing
and health care organizations and the development and implementation of health
policy.
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Within the DNP curriculum the AACN identifies two components; they are the eight
DNP Essentials for competencies for all DNP program graduates, and specialty
competencies for the DNP graduates that practice in particular specialties. The DNP
prepared nurse has many different roles and expectations that clearly evolve and grow
even after the program is completed.
With the ever evolving changes within care regimens and practice guidelines, it is
important to focus and adhere to the most up-to date evidence-based practice standards of
care, and to stay apprised and educated on new developments. It is important for the DNP
graduate understand how to utilize evidence-based practice, by being prepared to perform
critical appraisal of literature, apply practice guidelines, design and implement
evaluation practice outcomes (Terry, 2018).
The practicum setting that I conducted this research study from was an
endocrinology clinic that belongs to a corporation in which is rapidly growing and
expanding many clinics within the United States and other countries. This clinic utilizes
many different evidence-based models in order to provide the most up-to-date and quality
care for initializing individualized patient care regiments for treating diabetes. When
reflecting on the emphasis that this endocrinology clinic places on evidence-based
research and current practice guidelines, it is evident that their goals for patient outcomes
and clinical improvement are the driving force of their mission. This clinic strives for
improvement not only for the population living with diabetes, but within health care in
general. Another emphasized goal for this clinic is staying apprised and educated on the
evolution of new and improved ways to treat patients. This organization does utilize
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Afrezza and that is how I became interested in learning more of this new method of
administering insulin. As my knowledge grew on this topic, the more apparent it became
that not many healthcare providers are knowledgeable in regards to the inhaled insulin,
Afrezza. I have witnessed many times with in practice, the utilization of this rapid-acting
inhalable insulin, Afrezza change patient’s living with diabetes perception on their
disease process. This is a profound accomplishment in health science, there are many
patients that are suffering through five or more insulin injections a day, along with five or
more finger sticks a day in order to control their glucose levels. I found it necessary to
share these successful outcomes with my colleagues, other health care professionals and
my patient population for the improvement in quality of life for patients living with
diabetes.

Summary
In summary of section 2, a review of the concepts, models and theories utilized in
detail to give a better understanding of the methodology used during program planning,
designing, outlining research, implementing strategies and evaluation methods.
With the use of a pre-and posttest, evaluation was conducted throughout the entire
project of creating an educational program for the use of the inhaled insulin, Afrezza.
This program could help address the community gaps in health care for the population of
patients that are living with diabetes. By providing education on the inhaled insulin,
Afrezza, for health care providers that manage the care of patients living with diabetes,
will allow them an opportunity to offer an alternative medication regiment to their
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patients. This could improve their patient’s quality of life and improve their health
outcomes.

Section 3: Collection and Analysis of Evidence
Diabetes is on a global rise and there is a definite gap in providing care for the
diabetic population. One of the largest gaps in providing care for patients living with
diabetes is ensuring that health care providers stay apprised on the ever- evolving diabetic
treatment plans and medication regiments. Another identified gap is individualizing
diabetes plans of care according to a patient’s needs to assure adherence to prescribed
treatment.
The aim for this education program was to help close the gap within healthcare
practice when managing the care of patients living with diabetes. Identifying gaps within
health care providers knowledge base and providing them with education on the use of
the inhaled insulin, Afrezza, could promote an alternative method to managing glucose
levels that will improve patients’ quality of life and medication adherence. The adherence
to individualized care plans for patients living with diabetes could help in eliminating
rehospitalizations due to the multiple co-morbidities that are attributed to diabetes, and
reduce overall global health care expenditure due to diabetes management. The ultimate
goal of this educational module was to improve, support, and educate the global
population on the benefits of using the inhaled insulin, Afrezza, by means of educating
healthcare providers first.
Health care providers and the patient population living with diabetes could benefit
from this education module on the use of inhaled insulin. Health care providers could
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offer patients that have diabetes an alternative method of delivering insulin, possibly
resulting in improved patient outcomes and quality of life as well as the increased
provision of quality care. This educational module could also help health care providers
to stay updated on the evolution of modern technologies and medication regiments for
patients living with diabetes.
In this section I discuss the following four areas of focus for this project:
1. Clarifying the practice-focused questions and how they both align with
this doctoral project.
2. Clearly identifying the sources of evidence that were used, and how
they were obtained for the development of this project, including any
participants and their ethical protection.
3. Describing the systems used for analysis and synthesis in this project
to address the practice-focused question.
4. Summarizing of Section.

Practice-Focused Question(s)
There are two major contributors to the gap in providing health care for diabetes
management: the lack of collaboration between health care professionals and the lack of
education for health care providers on the most current practice guidelines for
individualized treatment plans for patients living with diabetes. It is almost impossible for
a health care provider to stay apprised on the ever- evolving diabetic treatment plans and
the preferred medication regiments that are on the pharmaceutical market.
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The guiding practice-focused questions for this project is:
1. If health care providers are educated on the guidelines for the use,
administration, and effectiveness of using the inhaled insulin, Afrezza, will
they be more likely to utilize this medication regimen for improving the
quality of life for patients living with diabetes?
2. Will the development of this educational module improve collaborative
measures within the health care professional’s practice for the growth and
improvement of the management of care for patients living with diabetes?
Managing the care of patients living with diabetes can be difficult for health care
providers due to the overwhelming number of medication treatment regiments available
for glycemic control. The rapid evolution of diabetes medication research updates at
times creates a barrier for healthcare providers in staying knowledgeable, and updated on
the wide variety of medications for treatment of diabetes. The world diabetes drug
market is valued at over 57 billion USD in 2018 and is estimated to reach 87 billion USD
by the end of 2025 (GlobeNewswire, 2020). There are hundreds of different diabetic
medications for Type 1 and Type 2 diabetes, including insulins and oral medications to
help meet glycemic control.
Over many decades, many different treatments and practice guidelines have
emerged for diabetes management. Injectable insulin has been utilized for over a century
for the control of glycemic levels in both Type 1 and Type 2 diabetes mellitus. For many
years, insulin injections have been the first choice as the treatment for diabetes due to
unestablished guidelines for the treatment of diabetes and health car providers’
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knowledge deficit of practice guidelines for managing diabetes. For almost a century,
there has been the idea of an alternative way to administer insulin by means of inhalation,
however through different trials and research programs there was little success in
implementing this theory until 2014 when the FDA approved the inhaled insulin,
Afrezza. This form of insulin has a rapid onset of approximately 10 minutes, its peak
action is strong. and it is metabolized within 90 minutes to avoid hypoglycemic events,
while other injectable insulins act too slow and metabolize much slower. (Edelman,
2020). Almost a decade has passed since the FDA approved Afrezza, and there is still a v
limited amount of health care providers and patients knowledgeable not only of the
existence of Afrezza, but the guidelines for its use, treatment, dosing, and maintenance.
Creating a pre- and posttest for this project helped to identify gaps in health care
providers’ knowledge base when managing diabetes. The creation of an educational
module on prescribing, administering, evaluating for effectiveness, and monitoring of the
inhaled insulin, Afrezza, along with the use of CGM’s could make a positive impact in
health care. Identifying areas of need in the nursing profession’s educational process is
necessary to recognize when nurses are deficient or lacking in educational development
in specific areas of their training. This allows for the healthcare professional to seek
continuing education for these deficiencies to avoid providing poor patient care and
medical errors. With the utilization of this educational module on the inhaled insulin,
Afrezza, healthcare providers could feel more knowledgeable and confident in offering a
different method of insulin administration.
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Sources of Evidence
I retrieved multiple sources of evidence on medication and treatment regimens
for managing diabetes for this project. Even though the inhaled insulin, Afrezza, has
been around for years, health care providers and patients still have many questions
regarding it. Recently, there have been an increasing amount of articles, studies,
presentations, and books to share information on the utilization of Afrezza.
Some of my primary sources of reference for this study were the ADA, CDC,
American Nurses Association, American Association of Diabetes Educators, and
MannKind Corporation. I also used peer-reviewed articles, conferences, presentations
based on evidence-based practice, pharmaceutical studies, and statistical outlines as
sources.
These sources of evidence were aligned with the purpose of this project because
they were based on evidence-based practice; current guidelines; statistics; and research
conducted by various organizations, health care professionals, scientists, and human
service programs. All these sources of evidence provided information to help in bridging
the gaps when providing health care for diabetes.
One of the key strategies for program planning in this project was to identify the
problem and its etiology. When designing a program for improvement within health care
that involves problem solving, it is important to choose a model that is based around a
theory that will help establish necessary steps to achieve desired outcomes (Kettner,
2017).
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During the evaluation of this educational project, I intended to analyze outcomes;
however, evaluation was an ongoing activity that actually started at the beginning of the
formulation of this research plan and continued even after the interventions were
completed. In this program, a pre-test was given to health care providers to evaluate their
knowledge level of diabetes treatment regimens, drug class updates, and treatment
guideline updates with a specific focus on the utilization of inhaled insulin. This test
allowed for the identification and determination of problematic areas. This focus
provided the opportunity to implement change within the educational process for
strengthening providers’ knowledge of evidence-based practice with the use of inhaled
insulin.
Next, I constructed an educational module with the compiled information to
provide education to providers on the guidelines for use, dosage titration, medication
management, and administration of inhaled insulin. This module was designed for
healthcare providers that are managing the care of Type 1 and Type 2 diabetes.
The final evaluation was conducted using the results of the post-test given to the
health care providers after completing the review of the educational project module with
virtual assistance through a Zoom conference. This helped evaluate if the healthcare
provider gained a better understanding of and knowledge on the use of inhaled insulin,
which was the ultimate goal for this project.
My utilization of the pre- and post-test was influenced by the Kirkpatrick
evaluation model. Several researchers noted that Kirkpatrick’s approach has been popular
as a model for evaluating learner outcomes in various training programs (Kurt, 2018).
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This model has contributed to educational evaluation with a focus on program outcomes
through the evaluation of how well the content was absorbed. There are four different
stages of evaluation: formative, process, impact, and outcome. Each stage begins at
different times in a research study process.
Some of the search engines, databases and key search terms used to find outcomes
and research related to the practice problem are:
•

Use of Afrezza

•

Gaps in healthcare when managing diabetes

•

What are the standards of medical care in diabetes?

•

How was inhaled insulin discovered?

•

When was Afrezza approved by FDA?

•

How did insulin get discovered?

•

Do healthcare workers understand the use of Afrezza?

•

Centers for Disease Control/Diabetes

•

American Diabetes Association/Afrezza

•

MannKind/Afrezza

•

Improved outcomes when using Afrezza

•

Theories and models for project formation

•

Theories and models for learning project evaluation outcomes

•

Understanding Kirkpatrick’s evaluation model.

There are many different databases and search engines that can be used for the
purposes of understanding the use of the inhaled insulin, Afrezza; defining gaps in
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providing health care for diabetes; and improving health care for the disease process of
diabetes. I completed comprehensive research for the purposes of this project and in full
alignment with the defined problem and practice-focused questions.
In terms of years searched, the scope of this review began in the early 1900’s.
Inhaled insulin was initially thought of in the 1920’s by German researchers (Vecchio,
2018). The FDA had approved one type of inhaled insulin in 2012 named Healio;
however, it failed to be used due to its administration device (Vecchio, 2018). In 2014
the FDA approved, Afrezza, and it is now the only successfully FDA- approved inhaled
insulin on the pharmaceutical market.
The participants in this project were 20 health care providers that manage the care
of patients living with diabetes. They were randomly selected out of health care
providers that I often collaborate with through my practice, some being primary care
providers, emergency medicine providers, urgent care providers, endocrinology
specialist, obstetrician-gynecologist providers, internal medicine providers, cardiologist
providers, and certified diabetic educators. I emailed special instructions to each
potential participant requesting their participation in this project study and providing
them with specific information on the steps necessary to participate without interfering
with the results or placing biased information within the outcomes of the study.
The techniques used to outline and evaluate the project for effectiveness was:
The first phase was that the pre-test was physically mailed to each participant in an
unmarked, non-numbered or trackable and ask that upon receipt and taking the pre-test
that it be returned in the pre-addressed, stamped envelope, without placing any
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identifying information on the test or envelope. After all of the pre-tests were received
back through the U.S. mail, the second step was implemented. The second step was that
a post-test, along with an educational module and an evaluation form, with a return, preaddressed, stamped envelopes was sent via U.S. mail. The third phase was a scheduled
virtual presentation was held with the participants one week after the post-test, evaluation
form and educational module was mailed. The fourth phase was requesting that after the
virtual presentation on the content of the educational module was completed, that the
participants complete the post-test, and evaluation form in the return, pre-addressed,
stamped envelopes that day.
The final phase was evaluating the pre and posttest along with the evaluation
forms for feedback for improvement measures, effectiveness of the educational module,
and presentation towards the practice focused questions and outcome goals. I protected
the participants within this project by removing any identifiers such as names, date of
birth, etc. There was no enrollment policies or obligations any further that the above
listed protocols. There was no patient information, identifiers or discussion in regards to
patient’s names, date of birth, case numbers, or identifiers utilized within this project.
There was no patient participation in this project.
The role of the Walden University Institutional Review Board (IRB) approval
# 06-23-21-0392772. in approval of the ethical protection of the participants within my
project; I filled out an application for their review for protection of participants identity.
The application was sent to the IRB department along with the completed and
administrator signed Site Approval Form filled from the research site that oversees the
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project. The steps for approval from the IRB was conducted after my chair had uploaded
the proposal into MyDR for the University Research and Review to review, and
approval was obtained, and I identified a site for my project to take place.

Analysis and Synthesis
The systems used for recording, organizing, and analyzing the information was by
excel spread sheet. There was no tracking needed for this project. The utilization of the
U.S. postal service was the delivery service used to send the project materials. The
computer program ZOOM was utilized for the review of the educational module with the
participants prior to them taking the posttest and filling out the evaluation form.
Some of the procedures that will be utilized in order to assure the integrity of the
evidence are:
1.

Not utilizing digital testing methods, I used paper format, in order for
results not to be manipulated or skewed.

2. Used unmarked, untrickable methods of communication in regards to
the pre and post-tests, evaluation forms, and envelopes.
3. Participants are health care professionals that was not be identified, it
was not necessary for the context of this project.
4. There was no patient participation, there was no patient scenarios
utilized in this project.
5. I utilized reputable resources in my research, in order to avoid
inappropriate manipulation, and incorrect data.
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6.

I used evidence-based practice research, along with peer reviewed
articles.

7. Within the pre and posttest and the evaluation form, the questions
selected had a combination of yes and no answers, multiple choice, in
order not to recognize hand writing or specific terminology that
created bias in the project outcomes.
The analysis procedures that were utilized for this doctoral project was a Gannt
Chart in order to stay on task for the time line and the objectives that need to be achieved.
Another analysis procedure that was used was the Fitzpatrick evaluation model, ensuring
that the project was effective through the design and by reviewing the participants gain of
knowledge after the completion of this program. The last analysis procedure was after
the completion of the project. An unbiased analysis was made of the outcomes of the
project in order to evaluate if the module, and review program had met the project goals
and addressed the practice-focused questions. The procedures to evaluate the post and
pretest scores include descriptive statistics and comparison of scores with percentages to
identify improvement in knowledge. Basic proportions and percentages were utilized as
well. Such as the example of Question #1 pretest will show 75% accuracy in response
and the posttest shows a 100% accuracy totaling a 25% improvement rate after the
educational module presentation.
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Summary
In summary, addressing the practice problems of this project; the gap in providing
healthcare for patients living with diabetes due to lack of collaboration, and the
knowledge deficit of health care providers when managing diabetes, is vital. It was
important to focus on the purpose of implementing positive change within society by
educating health care providers on the management of diabetes.
The alignment of the practice-focused question and the participants of the project
was vital for successfully addressing the practice problem. The participants for the
purpose of this project were health care providers that all manage the care of patients
living with diabetes, however they are all from different specialties in the health care
profession. Therefore, the project could in fact develop collaborative practices, and
increased the knowledge on the use of the inhaled insulin, Afrezza in order to promote
better patient outcomes.
It was important to use reputable sources of evidence that have direct
relationships with the practice-focused questions and the project goals. When designing a
project, it is necessary to define all terminology that could be foreign to participants and
stakeholders, this assures that clear, concise dialogue is presented during the project
phases. There are many ways to gather, track and obtain necessary research information
and it is vital to choose tools and techniques that will properly collect evidence that aligns
with the project and promote reliability in gathered information.
When choosing the participants for a project it was vial to ensure that they have a
profound purpose within the goals of my project. The purpose for the diversity in
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specialty areas of health care providers was that I chose for this project was to promote
collaboration within managing care for patients living with diabetes. It was important to
implement ethical tactics in order to promote privacy and protection for all participants
within the project, this also assisted with the prevention of bias influence in the project
outcomes.
It was imperative to utilize effective analysis and synthesis methods in order to
maintain the integrity of the project outcomes and evaluations for effectiveness. Using
specific procedures can assure that research findings and Implications for the project
were accurate without specific influence or delays in the expected time line.
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Section 4: Findings and Recommendations
Diabetes is on a global rise, and there is a definite gap in providing care for the
population of people living with diabetes. One of the largest gaps in providing care for
patients living with diabetes, is ensuring that health care providers stay apprised of the
ever-evolving diabetic treatment plans and medication regiments. Another identified gap
is individualizing diabetes plans of care according to a patient’s needs to assure
adherence to prescribed treatment regimens. Individualized plans of care can help to
assure adherence to prescribed treatment regimens.
There are two major contributors to the gap in providing health care for diabetes
management: the lack of education for health care providers on the most current practice
guideline for individualized treatment plans for patients living with diabetes, and the lack
of collaboration between health care professionals when managing diabetes.
The guiding practice-focused questions for this project were:
1. If health care providers are educated on the guidelines for the use,
administration, and effectiveness of the inhaled insulin, Afrezza, will they be
more likely to utilize this medication regimen for improving the quality of
life for patients living with diabetes?
2. Will the development of this educational module improve collaborative
measures within the health care professional’s practice for the growth and
improvement of the management of care for patients living with diabetes?
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The ultimate goal of this educational module was to improve, support and educate
the global population on the benefits of using the inhaled insulin, Afrezza, by means of
educating healthcare providers first.
This program did enhance health care providers’ knowledge by delivering an
educational module on the use of the inhaled insulin, Afrezza. Use of this educational
module could improve and promote individualized patient care plans. I developed the
educational program to promote collaboration with subsequent health care providers or
specialists to improve continuity and quality of care for patients that are living with
diabetes.

Findings and Implications
A pre and post-test were given to the 20 participating health care providers to
evaluate their knowledge level on four specific areas of focus with the management of
diabetes: diabetes treatment regimens; diabetes drug class updates; the guidelines for
treatment with the inhaled insulin, Afrezza; and the health care provider’s collaborative
practice habits when managing diabetes. The utilization of the pre- and post-test was
influenced by the Kirkpatrick evaluation model.(see Figure 2). Several researchers noted
that Kirkpatrick’s approach has been popular as a model for evaluating learner outcomes
in various training programs (Kurt, 2018). This model has contributed to educational
evaluation with a focus on program outcomes through the evaluation of how well the
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content was absorbed on four levels: reaction, learning, behavior, and results (Kurt,
2018). The reaction level is focused on how the participant reacted to the program, and
end-user feedback. The learning level is focused on if the participants’ knowledge base
improved, while the behavior level is focused on if their practice was improved by the
program training. Lastly, the results level is used to determine if the clinical outcomes or
overall program statistics improve.

At the beginning of this research project, I mailed 22 pre-tests were mailed out
through the U.S. mail service to health care providers in various organizations and
practices. All 22 pre-tests were received back; however, two had to be eliminated on
terms of bias that would have interfered with the study outcomes due to receiving them
back via fax and email. Only 20 were received back through the U.S. mail service in the
provided unmarked, untraceable form as the directions implicated. After receiving the
pre-tests back, I sent a packet via U.S. Postal Service to each participant. Each package
included instructions for guidance; an invitation to a Zoom conference for a program
review; a post-test; the education module with materials on the inhaled insulin, Afrezza;
and a return, self-addressed envelope. To review the educational module and materials, I
conducted a Zoom conference that all 20 participants logged on and joined that lasted 45
minutes on July 8, 2021 at 1200 CST. Instructions were reiterated to the participants for
clarification on how to complete and return the post-test through the U.S. Postal Service.
Time was allowed for questions and answers at the end. All 20 post-tests were received
in unmarked, nontraceable envelopes within 7 days after completion of the Zoom
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conference. I analyzed the data and calculated the results using statistical format. The
questions, answers, and statistical gains are displayed in Table 1

Table 1
Pre- and Posttest Results
Questions

Pre-test
Answers

Post-test
Answers

Yes-15
No-2
Not sure-2

Measured
Difference
Between Preand Post-test
outcomes
Yes-increased
by 5/50%
No-decreased
by 2/50%
Not sure—
decreased by
4/66%
One question
eliminated

Statistical
Improvement

1. Are you familiar and
comfortable with
utilizing the most
current diabetes
treatment regimens?

Yes-10
No-4
Not sure-6

2.Are you familiar and
comfortable with the
guidelines for treating
patients with the
inhaled insulin, Afrezza

Yes-0
No-18
Not sure-2

Yes-17
No-3
Not sure-0

Yes-increased
by 17/85%
No-decreased
by 15/83.3%
Not suredecreased by
2/100%

Improved 85% of
participating health
care providers
knowledge base on
the utilization of the
inhaled insulin,
Afrezza.

3.Will you prescribe
the inhaled insulin
Afrezza to manage type
1and type 2 diabetes?

Yes-2
No-18
Not sure-0

Yes-12
No-5
Not sure-3

Yes-increased
by 10/80%
No-decreased
by13/72.2%
Not sureincreased by
3/300%

Improved 80%
participating health
care providers that
will prescribe
inhaled insulin
Afrezza for
managing diabetes.

4.As a health care
provider do you

Yes-5
No-5

Yes-15
No-3

Yes-increased
by 10/100%

Improved 100%
participating health

Unanswered-1

Improved 50% of
participating health
care providers
knowledge and
comfort level with
the utilization of
diabetes treatment
regimens.
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practice collaborative
habits when managing
patients with diabetes.

Sometimes-10

Sometimes-2

No-decreased
by 2/40%
Sometimesdecreased by
6/80%

care providers
ideation of
collaborative habits
when managing
patients with
diabetes.

5.Do you think
utilizing the inhaled
insulin, Afrezza could
improve the quality of
life for patients with
diabetes?

Yes-8
No-0
Not sure-12

Yes-18
No-0
Not sure-2

Yes-Increased
by10/125%
No-unchanged
Not suredecreased by
10/125%

Improved by 125%
of the participating
health care
providers believe
that utilization of
Afrezza could
improve patient
quality of life.

6.Do you think
utilizing the inhaled
insulin, Afrezza could
promote improved
patient outcomes, due
to improved medical
adherence?

Yes-5
No-5
Not sure-10

Yes-15
No-2
Not sure-3

Yes-Increased
by 10/125%
No-decreased
by 3/60%
Not suredecreased by
7/70%

Improved by
125%of the
participating health
care providers
believe that
utilization of
Afrezza could
improve medical
adherence and
promote better
patient outcomes.

7. Do you think
utilizing the inhaled
insulin, Afrezza, with
concomitant use of
Continuous glucose
monitors could
decrease global
biohazardous materials,
such as insulin syringes
and hypodermic
needles and lancets?

Yes-8
No-10
Not sure-2

Yes-19
No-0
Not sure-1

Yes-increased
by 11/137.8%
No-decreased
by 100%
Not sure
decreased by
1/50%

Increased by
137.8% of
participating health
care providers
believe that
utilization of
Afrezza could
decrease
biohazardous
materials.

8. Do you think the
utilization of inhaled
insulin, Afrezza could
reduce global
expenditure on diabetes
management, such as
supplies, medication
costs and
rehospitalizations due
to diabetes?

Yes-4
No-12
Not sure-4

Yes-12
No-2
Not sure-6

Yes-increased
by 8/200%
No-decreased
by 10/250%
Not suredecreased by 2/
50%

Increased by 200%
of participating
health care
providers believe
that utilization of
Afrezza could
decrease global
expenditure on
diabetes
management.
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9. Do you think that
this
program/educational
module will influence
your practice in the
future when managing
diabetes?

Yes-2
No-12
Not sure-6

Yes-19
No-0
Not sure-1

Yes-Increased
by 17/850%
No-decreased
by 12/100%
Not suredecreased by
5/83.3%

Increased by 850%
of the participating
health care
providers believe
that this
program/educational
module will
influence their
practice with
managing diabetes.

10. Do you think that
this program will allow
you to offer your
patients an alternative
method to treating
diabetes?

Yes-5
No-10
Not sure-5

Yes-20
No-0
Not sure-0

Yes-increased
by 15/300%
No-decreased
by 10/100%
Not sure
decreased by
5/100%

Increased by 300%
of the participating
health care
providers believe
that this
program/educational
module will give
them an alternative
method to treating
diabetes.

I developed this educational module with the following goals of providing
positive social change: helping health care providers stay apprised of and educated on the
evolution of an alternative method of administering insulin, improving the quality of life
for the population living with diabetes, reducing health care costs, and reducing of
biohazardous material to promote echo-friendly measures.
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Figure 1
DATA Model
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Figure 2
Kirkpatrick’s Evaluation model that influenced pre- and post-test

Recommendations
This study’s outcomes showed a positive gain in providers’ knowledge on the use
of the inhaled insulin, Afrezza. More than half of the participants also gained a better
understanding of collaboration when providing care for diabetes. If replicated with use of
the educational module, these findings could improve the quality of care for patients
living with diabetes and promote better health outcomes. The outcomes of this study also
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implied that a 137.3% change was made in the belief of the participating health care
providers that with the use of inhaled insulin and CGM’s that biohazardous material
could be reduced. This educational module/program could promote social change due to
the positive gain of knowledge that was demonstrated by the pre- and post-test evaluation
tool. An 850% gain was accomplished with the utilization of this module, in respect to
the participants changing their opinions on the fact that this program would influence
their future practice.

Strengths and Limitations of the Project
One of the strengths of this project was that all biased material was eliminated
upon the recognition and receipt of electronically submitted pre-tests allowing
trackability. Another strength of this project was that the participants were health care
providers from various organizations and types of health care practices, which did not
limit the width of knowledge base to solely diabetes. A final strength of this program was
the ability to stress the importance of and promote collaborative practice in all realms of
health care.
One of the limitations of this project was the size of the study group, which was
limited to 20 people. Another limitation of this project was that there was no evidence
based-practice patient examples used to reinforce statistical findings. A final limitation
was that the time frame of the study was limited, based on one study group, and not
performed more than once to develop validity through repetition.
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Section 5: Dissemination Plan
My future plans for the dissemination of this DNP doctoral project include
speaking at the Advanced Diabetes Care and Education Conference. I have recently been
asked to speak at a MannKind Corporation meeting to educate other health care providers
on the guidelines for the utilization for the inhaled insulin, Afrezza. Another formal plan
for disseminating this project and the final outcomes is to provide the practicum location
with the study outcomes. This will be done to promote the theory of organizational
change. This organization uses the inhaled insulin, Afrezza, for the treatment of their
patients living with diabetes often, and promoting the use of the theory as well could
benefit to their corporation’s advancements.
This educational program was structured to advance health care providers’
knowledge base on the guidelines and use of the inhaled insulin, Afrezza. The aim of the
project was to promote positive social change through collaboration, improving medical
adherence, reducing global expenditure for the treatment of diabetes, and reducing
biohazardous material by educating health care providers first.
Analysis of Self
As a nurse practitioner, scholar, and the project manager, it was important for me
to utilize the six stages of Blooms Taxonomy: create, evaluate, analyze, apply,
understand and remember. (see Vanderbilt University Center for Teaching, 2017). The
creation of this educational module and research project was from my professional
experiences with the utilization of the inhaled insulin, Afrezza. The positive experiences
that I professionally have witnessed through evidence-based practice were intriguing. It
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was of great interest to me as to why there was not more information or education
available on this alternative method of administering insulin.
The evaluation stage was implemented throughout the entire project because, I
wanted to ensure that this educational program had meaningful use and could help
promote positive change within health care, and patients’ lives. I constantly evaluated
the progression and the need for necessary changes throughout each step.
During the analyzation phase, I wanted to ensure that I assisted other health care
professionals that manage the care for patient’s living with diabetes to understand the
guidelines for the inhaled insulin, Afrezza. I also wanted the learner to understand how
inhaled insulin could impact a patient’s life positively if utilized correctly. I have
personally witnessed many patients successfully reach optimal A1C reduction, and daily
glucose levels with the Afrezza medication regiment, and as a health care provider, it is
gratifying to watch your patients succeed.
Within the application process, I wanted to make sure that the information I was
presenting was effective and understandable to promote evidence-based practice. It was
important for me to convey to other health care providers that the utilization of the
inhaled insulin, Afrezza, could literally change some of their patients’ lives. As a health
care provider, Afrezza has given me a different perspective on insulin administration.
Through the application process my goal was to share my knowledge by clearly
communicating the benefits of this medication to patients living with diabetes.
In terms of the phase of understanding, it was valuable to have had the
opportunity to study, research, and experience evidence-based practice and theories
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related to the use of the inhalable insulin, Afrezza, for over a year and a half prior to this
study. I wanted to make sure that the participants of this project understood this
medication regiment; however, if they did not fully understand the guidelines for inhaled
insulin after the educational module was completed, they would have ample resources to
further explore.
When the educational module and presentation of review was completed, I
wanted to ensure that health care providers remembered the content. It was important for
me to make the information, accessible and easy to interpret. I wanted to place the
obligation for patient education on the health care providers and help them understand the
importance of staying apprised on the evolution of pharmaceutical regiments. I also
wanted to assist with conveying the need for collaborative practice, and help them
remember its importance for improved patient outcomes. No single person can possibly
know and remember everything when it comes to the millions of disease processes and
their detail.

Summary
In conclusion, my goal of creating an educational module for health care
providers to improve the management of diabetes with the utilization of the inhaled
insulin, Afrezza, proved to be effective through this project study. This educational
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module is a possible way of taking positive steps towards improving the quality of life
and health outcomes of patients living with diabetes. This project also proved that
improving health care providers knowledge on managing diabetes with the inhaled
insulin, Afrezza, could promote positive social change. The utilization of inhalable
insulin could lower the overall global expenditure on diabetes and the multiple
comorbidities that come with this disease process. The use of Afrezza could also lead to
positive change in health care by improving patient outcomes and medical adherence as
well as decreasing hospitalizations due to diabetic influence.
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